Hot Features
Premium
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Zeitraum:
Zeichenmodus:
| Volumen | 14.268 |
|
|||||
| News | - | ||||||
| Tageshoch | 2,56 | Niedrig Hoch |
|||||
| Tagestief | 2,38 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Incannex Healthcare Ltd | IXHL | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,16 | -6,27% | 2,39 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 2,51 | 2,38 | 2,56 | 2,39 | 2,55 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 212 | 14.268 | US$ 2,48 | US$ 35.389 | - | 0,80 - 12,68 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 23:25:31 | 49 | US$ 2,3806 | USD |
Finanzwerte IXHL
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 793,66k | 15,87M | - | 1,01M | -19,98M | -1,26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Incannex Healthcare
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 16.4.2024 | 14:00 | GlobeNewswire Inc. | Incannex Healthcare Inc. Quarterly Update, Q1 2024 |
| 28.2.2024 | 13:30 | GlobeNewswire Inc. | Incannex Announces Positive Topline Results from Phase 2.. |
| 16.2.2024 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 16.2.2024 | 13:30 | GlobeNewswire Inc. | Incannex Completes Successful Pre-IND Meeting with the FDA.. |
| 14.2.2024 | 12:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 01.2.2024 | 13:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 01.2.2024 | 13:30 | GlobeNewswire Inc. | Clarion Clinics Open for Psychedelic-Assisted Treatments |
| 24.1.2024 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 24.1.2024 | 22:05 | GlobeNewswire Inc. | Incannex Commences Dosing in Phase 2 Clinical Trial.. |
| 18.1.2024 | 15:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 18.1.2024 | 14:22 | GlobeNewswire Inc. | Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD”.. |
| 17.1.2024 | 13:30 | GlobeNewswire Inc. | Incannex Receives IRB Approval for the RePOSA Phase 2/3.. |
Forum Incannex Healthcare
Keine Diskussionen Gefunden.Neuen Thread Erstellen
IXHL Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 2,23 | 2,94 | 2,20 | 2,64 | 19.507 | 0,16 | 7,17% |
| 1 Monat | 3,4278 | 3,435 | 2,13 | 2,70 | 19.325 | -1,04 | -30,28% |
| 3 Monate | 3,28 | 8,4697 | 2,13 | 5,71 | 339.360 | -0,89 | -27,13% |
| 6 Monate | 1,07 | 12,68 | 0,80 | 5,85 | 197.690 | 1,32 | 123,36% |
| 1 Jahr | 2,00 | 12,68 | 0,80 | 4,88 | 130.926 | 0,39 | 19,50% |
| 3 Jahre | 11,00 | 90,00 | 0,80 | 7,23 | 90.109 | -8,61 | -78,27% |
| 5 Jahre | 11,00 | 90,00 | 0,80 | 7,23 | 90.109 | -8,61 | -78,27% |
